Huvitz Co Ltd
KOSDAQ:065510
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (20.2), the stock would be worth ₩13 807.42 (73% upside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 11.7 | ₩7 960 |
0%
|
| 3-Year Average | 20.2 | ₩13 807.42 |
+73%
|
| 5-Year Average | 13.1 | ₩8 915.57 |
+12%
|
| Industry Average | 13.6 | ₩9 265.18 |
+16%
|
| Country Average | 10 | ₩6 811.21 |
-14%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
H
|
Huvitz Co Ltd
KOSDAQ:065510
|
84B KRW | 11.7 | -16.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
161B USD | 16.9 | 25.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.3B USD | 50.9 | 56.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.2B USD | 27 | 38.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
105.2B USD | 17.1 | 22.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
88.3B USD | 21.5 | 30.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
42.9B EUR | 16.4 | 20.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.3B USD | 26.5 | 43.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.4B USD | 38.7 | 42.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.6B USD | 17.9 | 25.4 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
32.9B USD | 19.1 | 15.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 5.8 |
| Median | 10 |
| 70th Percentile | 18.7 |
| Max | 2 215 163.4 |
Other Multiples
Huvitz Co Ltd
Glance View
Huvitz Co., Ltd. engages in the development of ophthalmic equipment. The company is headquartered in Anyang, Gyeonggi-Do. The company went IPO on 2003-10-31. The Company’s products include ophthalmic and optical equipment as well as micro scope systems. Its ophthalmic and optical equipment consists of refractive instruments, such as auto ref-keratometers, auto lens meters, digital refractors, chart projectors and unit tables; diagnostic instruments, such as slit-lamps, non-contact tonometers and applanation tonometers, as well as lens-edging instruments. Its microscope systems consist of stereo microscopes, upright microscopes and imaging solutions. The firm distributes its products within domestic market and to overseas markets, including America, Europe and Japan.
